| Title : FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models - O'Farrell_2022_Sci.Rep_12_15661 |
| Author(s) : O'Farrell M , Duke G , Crowley R , Buckley D , Martins EB , Bhattacharya D , Friedman SL , Kemble G |
| Ref : Sci Rep , 12 :15661 , 2022 |
| Abstract : |
| PubMedSearch : O'Farrell_2022_Sci.Rep_12_15661 |
| PubMedID: 36123383 |